Chemours (CC) Equity Income (2014 - 2026)

Chemours has reported Equity Income for 13 years, with the latest figure at $9.0 million in Q2 2026.

• On a quarterly basis, Equity Income changed 0.0% year-over-year to $9.0 million in Q2 2026; TTM through Jun 2026 was $34.0 million, a 8.11% decrease from a year earlier, with the FY2025 full-year figure at $35.0 million, down 18.6% from the prior year.
• Equity Income was $9.0 million for Q2 2026 at Chemours, up from $8.0 million in the prior quarter.
• The five-year high for Equity Income was $16.0 million in Q2 2022, with the low at $7.0 million in Q4 2023.
• Average Equity Income over 5 years is $10.8 million, with a median of $11.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Equity Income soared 60.0% in 2022, then sank 38.46% in 2025.
• Over 5 years, Equity Income stood at $11.0 million in 2022, then sank by 36.36% to $7.0 million in 2023, then climbed by 28.57% to $9.0 million in 2024, then slipped by 11.11% to $8.0 million in 2025, then gained by 12.5% to $9.0 million in 2026.
• The last three Equity Income figures came in at $9.0 million (Q2 2026), $8.0 million (Q1 2026), and $8.0 million (Q4 2025), per Business Quant data.